NEVVI Medicare utilization intelligence

← back

YANG, ANDREWM.D. NPI 1316232168 Clinician

Hematology-Oncology · EVERETT, WA

Specialty Hematology-Oncology — from billed Medicare claims
Trained STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER — medical school, self-reported to CMS
In practice about 15 years since medical school (class of 2011, self-reported to CMS)
Location EVERETT, WA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 44 codes billed · 42,210 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20202026
OPTUM CARE WASHINGTON PLLC
2020–2026
WHIDBEY ISLAND PUBLIC HOSPITAL DISTRICT
2023
THE POLYCLINIC
2022
WHIDBEY ISLAND PUBLIC HOSPITAL DISTRICT
2020

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2019-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J9267 Injection, paclitaxel, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
J9045 Injection, carboplatin, 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83540 Iron level
84466 Transferrin (iron binding protein) level
82728 Ferritin (blood protein) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82784 Gammaglobulin (immune system protein) measurement
83735 Magnesium level
96417 Administration of additional new drug or substance into vein, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
84443 Blood test, thyroid stimulating hormone (tsh)
J3489 Injection, zoledronic acid, 1 mg
96415 Administration of chemotherapy into vein, each additional hour
83615 Lactate dehydrogenase (enzyme) level
J1200 Injection, diphenhydramine hcl, up to 50 mg
96372 Injection of drug or substance under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
84439 Thyroxine (thyroid chemical), free
84153 Psa (prostate specific antigen) measurement, total
96361 Infusion into a vein for hydration, each additional hour
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99451 Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes
96523 Irrigation of implanted venous access drug delivery device
J7030 Infusion, normal saline solution , 1000 cc
96411 Administration of additional new drug or substance into vein using push technique
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
82607 Cyanocobalamin (vitamin b-12) level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.